ALSEA:BMVAlsea, S.A.B. de C.V. Analysis
Data as of 2026-05-26 - not real-time
MX$51.36
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Alsea is navigating a mixed landscape where technical signals point to short‑term weakness while fundamental indicators and analyst sentiment suggest medium‑to‑long‑term upside. The short‑term moving average sits below the medium‑term average, the RSI is below the midpoint, and volume has been trending down, all of which reinforce a bearish bias on the near horizon. At the same time, the MACD histogram has turned positive, the dividend payout remains modest relative to cash generation, and the company boasts a strong return on equity and solid operating cash flow.
The valuation picture is nuanced: the discounted cash flow model places the fair value below the current market price, hinting at a premium, yet analysts maintain a buy consensus with target levels well above today’s price, implying perceived upside. High volatility and a low beta suggest price swings but limited systematic risk, while the balance sheet shows a very high leverage ratio that could constrain flexibility. Overall, the stock appears positioned for a cautious hold in the short run, with potential for accumulation if the macro environment stabilizes and the company can translate its cash flow strength into earnings growth.
The valuation picture is nuanced: the discounted cash flow model places the fair value below the current market price, hinting at a premium, yet analysts maintain a buy consensus with target levels well above today’s price, implying perceived upside. High volatility and a low beta suggest price swings but limited systematic risk, while the balance sheet shows a very high leverage ratio that could constrain flexibility. Overall, the stock appears positioned for a cautious hold in the short run, with potential for accumulation if the macro environment stabilizes and the company can translate its cash flow strength into earnings growth.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- technical indicators showing bearish momentum
- decreasing trading volume
- price hovering near recent support
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- analyst consensus and target price upside
- strong cash flow and modest dividend payout
- potential for operational improvements and margin expansion
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- robust brand portfolio across multiple geographies
- consistent return on equity and operating cash generation
- capacity to leverage market positioning as consumer spending recovers
Key Metrics & Analysis
Financial Health
Revenue Growth0.30%
Profit Margin2.45%
P/E Ratio17.1
ROE25.39%
ROA6.56%
Debt/Equity574.80
P/B Ratio4.6
Op. Cash FlowMX$16.7B
Free Cash FlowMX$6.1B
Technical Analysis
TrendBearish
RSI42.1
SupportMX$49.84
ResistanceMX$54.04
MA 20MX$52.03
MA 50MX$54.56
MA 200MX$54.60
MACDBullish
VolumeDecreasing
Fear & Greed Index91.8
Valuation
Fair ValueMX$43.34
Target PriceMX$68.94
Upside/Downside34.23%
GradeOvervalued
TypeValue
Dividend Yield1.94%
Risk Assessment
Beta0.40
Volatility26.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.